Sustained potassium control and recurrent hyperkalemia during individualized potassium-guided sodium zirconium cyclosilicate titration in maintenance hemodialysis: a post hoc analysis of a randomized trial
Haiming Wang, Wei Zhou, Yan Jiang · 2026
Read Sustained potassium control and recurrent hyperkalemia during individualized potassium-guided sodium zirconium cyclosilicate titration in maintenance hemodialysis: a post hoc analysis of a randomized trial by Haiming Wang, Wei Zhou, Yan Jiang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13670448.txt.
Description
Wang, Zhou, and Jiang analyse potassium control in dialysis patients in twenty twenty-six. High potassium is a chronic risk for people on maintenance haemodialysis. A single visit average cannot show if control holds month after month. The team studied a drug, called SZC, dosed by each patient's own potassium levels.
The analysis uses data from a trial of one hundred sixteen patients, split evenly by group. Sustained response meant most monthly measures stayed in range during months three to six. That outcome occurred in about forty-three percent of treated patients and fourteen percent of controls. Repeat high potassium readings were far less common in the treated group. The authors stress that clinical outcomes were not assessed. Better lab control alone does not prove clinical benefit.
Catalog record
| CREATOR | Haiming Wang, Wei Zhou, Yan Jiang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |